menu
    • menu

    Company profile for Mesoblast

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mesoblast is a world leader in developing innovative cellular medicines.The Company has established what it believes is the industry’s most clinically advanced and diverse portfolio of cell-based product candidates with three programs in Phase 3 clinical studies. Consistent and durable clinical outcomes have been demonstrated across multiple difficult-to-treat diseases.The Company has leveraged its proprietary technology pla...
    Mesoblast is a world leader in developing innovative cellular medicines.The Company has established what it believes is the industry’s most clinically advanced and diverse portfolio of cell-based product candidates with three programs in Phase 3 clinical studies. Consistent and durable clinical outcomes have been demonstrated across multiple difficult-to-treat diseases.The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MesoblastAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    55 Collins Street Level 38 Melbourne 3000
    Telephone
    Telephone
    +61 3 9639 6036
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mesoblast.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/mesoblast
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mesoblast to Attend Piper Sandler Conference
    Mesoblast to Attend Piper Sandler Conference

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3199432/0/en/Mesoblast-Participation-at-Piper-Sandler-Conference.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Mesoblast Partners with NIH for Pivotal aGvHD Cell Therapy Trial
    Mesoblast Partners with NIH for Pivotal aGvHD Cell Therapy Trial

    24 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/mesoblast-teams-with-nih-to-launch-pivotal-trial-of-life-saving-cell-therapy-in-adults-with-severe-agvhd-18331

    INDPHARMAPOST
    24 Nov 2025
    Share Share
    Mesoblast Reports Strong Growth In Ryoncil Revenue At AGM Meeting
    Mesoblast Reports Strong Growth In Ryoncil Revenue At AGM Meeting

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193991/0/en/Mesoblast-Trading-Update-at-Annual-General-Meeting-Highlights-Continued-Strong-Growth-in-Ryoncil-Revenue.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Mesoblast, BMT CTN Launch Ryoncil® Trial for Severe Acute GVHD
    Mesoblast, BMT CTN Launch Ryoncil® Trial for Severe Acute GVHD

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192470/0/en/Mesoblast-and-BMT-CTN-to-Initiate-Pivotal-Trial-of-Ryoncil-as-Part-of-First-Line-Regimen-in-Adults-with-Severe-Acute-GVHD-Refractory-to-Steroids.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    James M. O'brien Appointed Chief Financial Officer at Mesoblast
    James M. O'brien Appointed Chief Financial Officer at Mesoblast

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3188807/0/en/James-M-O-Brien-Appointed-Chief-Financial-Officer-at-Mesoblast.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Mesoblast To Discuss Rexlemestrocel-L & Opioid Cessation
    Mesoblast To Discuss Rexlemestrocel-L & Opioid Cessation

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3181021/0/en/Mesoblast-to-Meet-With-FDA-Next-Month-to-Discuss-Rexlemestrocel-L-and-Opioid-Cessation.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search